Use of deprenyl to rescue damaged nerve cells

Details Use of deprenyl to rescue damaged nerve cells Use of deprenyl to rescue damaged nerve cells

1994-02-28

1995-08-22

Richter, Johann

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A01N 3302, A01K 31135

Patent

active

054440955

ABSTRACT:
The present invention relates to the use of deprenyl or derivatives or analogues of deprenyl to rescue damaged nerve cells in an animal; to pharmaceutical compositions containing deprenyl adapted for such use; and, to methods for the treatment of disorders of the nervous system by rescuing damaged nerve cells.

REFERENCES:
patent: 4861800 (1989-08-01), Buyske
patent: 4960797 (1990-10-01), Ecsery et al.
Tatton W. G. et al: "Rescue of dying neurons: A New Action for Deprenyl in MPTP Parkinsonism", & J. Neurosci. Res. 30/4 (666-672) 1991, Abstract.
Tatton W. G. et al: "Interactions between MPTP-induced and age-related neuronal death in murine model of Parkinson's disease", & Can. J. Neurol. Sci. 19/1 Suppl. (124-133) 1992, Abstract.
Rinne J. D. et al: "Selegiline (deprenyl) treatment and death of nigral neurons in Parkinson's disease", & Neurology 41/6 (859-861) 1991, Abstract.
Rinne J. D: "Nigral degeneration in Parkinson's disease in relation to clinical features", & Acta Neurol. Scnd. Suppl. 84/136 (87-90) 1991 Abstract.
Matsui Y et al.: "Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia", & Neurosci. Lett. 126/2 (176-178) 1991, Abstract.
Journal of Neural Transmission, vol. 64, 1985, W. Birkmayer et al.: "Increased Life Expectancy Resulting from Addition of L-Deprenyl to Madapar Treatment in Parkinson's Disease: A Longterm Study", Abstract.
Seniuk et al., Brain Research 527:7-20, 1990.
Tatton et al., Brain Research 527:21-31, 1990.
Juorio et al., Journal of Neurochem., 56:213-220, 1991.
G. Zsilla et al., Pol. J. Pharmacol. Pharm., 38:57-67, 1986.
G. Zsilla and J. Knoll, Typical and Atypical Antidepressants: Molecular Mechanisms, E. Costa and G. Racagni, eds., Raven Press, New York, 1982.
G. Zsilla et al., European Journal of Pharmacology, 89:111-117, 1983.
Tatton et al., Can. J. Neurol. Sci., 19:124-133, 1992.
Tatton et al., J. of Neuroscience Research, 30:666-672, 1991.
Tatton et al., Neurobiology of Aging, 12:543-556, 1991.
Greenwood et al., Neurobiology of Aging, 12:557-565, 1991.
Tatton et al., Neuroscience Letters, 131:179-182, 1991.
Tatton et al., Neuroscience Letters, 131:179-182, 1991.
Zsilla et al., Neurochemical evidence . . . , CA102(25):215050b, 1984.
Heikkila et al., Dopaminergic neurotoxicity . . . , CA102(7):57406r, 1985.
Torok et al., Transmitter releasing . . . , CA107(23):211830m, 1987.
Finnegan et al., Protection against . . . , CA113(17):145283f, 1990.
Merck, 11th edition, entries 2893, 6988, 1983.
Tiner, Acta Physiol Hung 1989, 74(3-4):259-66 abstract.
Jonakat, et al, Brain Res, 1988, Nov. 15, 473(2)336-43, abstract.

Affiliated with

Also associated with

Rating

Use of deprenyl to rescue damaged nerve cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of deprenyl to rescue damaged nerve cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of deprenyl to rescue damaged nerve cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2142222